Purpose The first part of this review focuses on the role of cells and molecules of adipose
tissue involved in metabolic syndrome-induced inflammation and in the maintenance of this …

The relationship among chronic low-grade inflammation, insulin resistance and other
obesity-associated metabolic disturbances is increasingly recognized. The possible …

In the genesis and progression of cardiovascular and metabolic diseases (CVMDs), adipose
tissue plays a pivotal and dual role. Complement factor D (CFD, also known as adipsin) …

Objective Osteoarthritis (OA), the most encountered arthritis form, result from degeneration of
articular cartilage. Obesity is accepted as a significant risk factor for knee OA (KOA). In this …

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent
synovial inflammation and irreversible cartilage and bone damage. Despite its predominant …

Metabolic syndrome (MS) is a group of clinical abnormalities characterized by central or
abdominal obesity, hypertension, hyperuricemia, and metabolic disorders of glucose or lipid …

Background: Obesity is characterized by a low-intensity chronic inflammatory process in
which immune system cells interact in a complex network, which affects systemic metabolic …

Obesity is a worldwide public health problem that has been increasing in the last decades. It
is characterized by excessive fat accumulation, and accompanied by low-grade chronic …

Several studies reported the effect of obesity on the progression of IgA nephropathy (IgAN).
However, the impact of obesity on the clinicopathologic presentation of IgAN remains …

Obesity-related glomerulopathy (ORG) is a secondary glomerular disease caused by
obesity, with clinical manifestations such as proteinuria and glomerulomegaly. Currently, the …